NOTCH1 and lung carcinoma: To better understand resistant cancer cell heterogeneity, we isolated a novel riboflavin+NOTCH1+ population from cisplatin-naïve and -resistant lung cancer cell lines and patient specimens with or without immunotherapy and chemotherapy.